Results 281 to 290 of about 22,583 (294)

Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic

Annals of Nuclear Medicine, 2020
Haladhar Dev Sarma, Rubel Chakravarty, Sudipta Chakraborty   +2 more
exaly  

Drug and gene targeting to the brain with molecular trojan horses

Nature Reviews Drug Discovery, 2002
William M Pardridge, Yoon Kyung Jeon
exaly  

Radiopharmaceutical licensing

Nuclear Medicine Communications, 1992
openaire   +2 more sources

Chelators and metal complex stability for radiopharmaceutical applications

Radiochimica Acta, 2019
Heather M Hennkens, Silvia S Jurisson
exaly  

Radioactive Main Group and Rare Earth Metals for Imaging and Therapy

Chemical Reviews, 2019
Thomas I Kostelnik, Chris Orvig
exaly  

Lutathera®: The First FDA- and EMA-Approved Radiopharmaceutical for Peptide Receptor Radionuclide Therapy

Pharmaceuticals, 2019
Klaus Kopka, Ute Hennrich
exaly  

Spatiotemporal multi-scale modeling of radiopharmaceutical distributions in vascularized solid tumors

Scientific Reports, 2022
exaly  

Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion

Nuclear Medicine and Biology, 2007
Mark A Green
exaly  

Radioactive Transition Metals for Imaging and Therapy

Chemical Reviews, 2019
Alan B Packard, Eszter Boros
exaly  

Radiopharmaceuticals

2012
openaire   +1 more source